Pages that link to "Q54464591"
Jump to navigation
Jump to search
The following pages link to A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice. (Q54464591):
Displaying 32 items.
- Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines (Q28067124) (← links)
- Proteomic survey of the pathogenic Mycoplasma hyopneumoniae strain 7448 and identification of novel post-translationally modified and antigenic proteins (Q33267213) (← links)
- Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses (Q33743411) (← links)
- Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D. (Q34920929) (← links)
- A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses (Q35095758) (← links)
- Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs (Q35140889) (← links)
- Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens (Q35252487) (← links)
- Comparison of a live attenuated Salmonella Enteritidis vaccine candidate secreting Escherichia coli heat-labile enterotoxin B subunit with a commercial vaccine for efficacy of protection against internal egg contamination by Salmonella in hens. (Q35652988) (← links)
- Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin (Q38636937) (← links)
- Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice (Q36106791) (← links)
- Non-toxic derivatives of LT as potent adjuvants. (Q37821530) (← links)
- Mycoplasma hyopneumoniae: from disease to vaccine development (Q38107293) (← links)
- A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice. (Q38747253) (← links)
- Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control. (Q40082569) (← links)
- Evaluation of a multi-epitope subunit vaccine against avian leukosis virus subgroup J in chickens (Q41098290) (← links)
- Characterization of a Salmonella Typhimurium ghost carrying an adjuvant protein as a vaccine candidate for the protection of chickens against virulent challenge (Q41729708) (← links)
- Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection (Q42204341) (← links)
- Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs. (Q42210386) (← links)
- Adjuvant effect of Escherichia coli heat labile enterotoxin B subunit against internal egg contamination in domestic fowl immunised with a live Salmonella enterica serovar Enteritidis vaccine. (Q45083603) (← links)
- Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine (Q46602469) (← links)
- Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin (Q47123471) (← links)
- Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB. (Q49054077) (← links)
- Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs (Q49065309) (← links)
- Molecular characterization of the recombinant protein RmLTI-BmCG-LTB: Protective immunity against Rhipicephalus (Boophilus) microplus (Q50133339) (← links)
- Development of Mycoplasma hyopneumoniae Recombinant Vaccines (Q50861611) (← links)
- Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice (Q81583836) (← links)
- Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae (Q84886263) (← links)
- Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines (Q85396240) (← links)
- Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae by a Baculovirus Expression System (Q90040198) (← links)
- Analysis of swine antigen-specific antibody responses to Mycoplasma hyopneumoniae infection determined by protein microarray (Q92081611) (← links)
- Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae (Q93161362) (← links)
- Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2 (Q99556547) (← links)